A PYMNTS Company

US: Rite Aid files antitrust claim against maker of acne drug

By  |  April 16, 2015

Rite Aid Corp. is claiming Medicis Pharmaceutical Corp., the manufacturer of acne treatment drug Solodyn, filed improper petitions and arranged unlawful agreements with their competitors to keep generic versions of Solodyn from reaching the market.

Rite Aid made the claims in an antitrust lawsuit filed in U.S. District Court for the Middle District of Pennsylvania on April 16.

“Medicis orchestrated a scheme to delay and suppress generic competition with respect to Solodyn and to maintain and extend its monopoly in the market for minocycline hydrochloride extended release tablets, to the detriment of Plaintiffs and other purchasers of the drug,” the suit reads.

 

Full Content: The Pennsylvania Record

 

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.